China Shineway Pharmaceutical Group Ltd banner
C

China Shineway Pharmaceutical Group Ltd
OTC:CSWYY

Watchlist Manager
China Shineway Pharmaceutical Group Ltd
OTC:CSWYY
Watchlist
Price: 19.25 USD Market Closed
Market Cap: $727.1m

China Shineway Pharmaceutical Group Ltd
Investor Relations

In the bustling world of pharmaceuticals, China Shineway Pharmaceutical Group Ltd. stands as a noteworthy player adeptly navigating the intricate channels of traditional Chinese medicine and modern pharmaceutical practices. Established in 1996, the company has rooted its foundation in the age-old wisdom of Chinese herbal medicine, while seamlessly integrating contemporary manufacturing methods. Headquartered in the industrial city of Shijiazhuang, Shineway has grown into one of China's top pharmaceutical enterprises, distinguished by its commitment to quality and innovation in healthcare solutions. At the heart of Shineway's operations is a robust production line that focuses on the development and distribution of herbal-based medicines, granules, and injections that cater to a diverse array of health needs, ranging from respiratory ailments to cardiovascular conditions.

Shineway's journey to profitability hinges on a well-crafted strategy of combining the trusted efficacy of traditional Chinese cures with rigorous scientific validation and modern production processes. With a comprehensive distribution network spanning domestic markets and cautiously expanding international borders, the company has managed to effectively channel its products through hospitals, clinics, and retail pharmacies. Their financial success is further bolstered by substantial investments in technology and research, allowing Shineway to continuously refine its offerings and maintain competitive prices. In an era where the global health landscape is constantly evolving, China Shineway Pharmaceutical Group Ltd. thrives by striking a delicate balance between preserving traditional medicinal heritage and embracing the advancements of contemporary pharmaceutical sciences, thereby securing a steady revenue stream while fostering broader acceptance of traditional Chinese medicine across the globe.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Zhenjiang Li
Co-Founder & Executive Chairman
No Bio Available
Ms. Yunxia Xin
Co-Founder & Executive Director
No Bio Available
Mr. Huimin Li
Executive Director
No Bio Available
Mr. Bun Ching Lee
Financial Controller & Company Secretary
No Bio Available
Mr. King Kuen Hung AICPA, HKICPA, MBA
Director of Investor Relation
No Bio Available
Mr. Yudong Zhang
General Manager of Sales & Marketing
No Bio Available

Contacts

Address
HEBEI
Shijiazhuang
Luancheng
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett